tm
Seeing Is Believing
tm
Seeing Is Believing
NLTX is currently covered by 1 analysts with an average price target of $-8.41. This is a potential upside of $-23.51 (-155.7%) from yesterday's end of day stock price of $15.1.
Neoleukin Therapeutics's activity chart (see below) currently has 6 price targets and 6 ratings on display. The stock rating distribution of NLTX is 100% HOLD.
Analysts average stock forecasts to be materialized ratio is 76.19% with an average time for these price targets to be met of 376.86 days.
Highest price target for NLTX is $18, Lowest price target is $18.
Most recent stock forecast was given by MARA GOLDSTEIN from MIZUHO on 09-May-2023. First documented stock forecast 18-Feb-2020.
Currently out of the existing stock ratings of NLTX, 1 are a HOLD (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$7.5
$-7.6 (-50.33%)
$10
2 years ago
(09-May-2023)
3/3 (100%)
$-10.3 (-57.87%)
252
Buy
$30
2 years 5 months 22 days ago
(16-Nov-2022)
1/2 (50%)
$8.6 (40.19%)
584
Hold
$4.5
$-10.6 (-70.20%)
$90
2 years 5 months 23 days ago
(15-Nov-2022)
1/2 (50%)
$-4 (-47.06%)
365
Hold
$100
2 years 5 months 23 days ago
(15-Nov-2022)
1/1 (100%)
$-122.2 (-55.00%)
643
Buy
$15
$-0.1 (-0.66%)
2 years 7 months 26 days ago
(12-Sep-2022)
2/2 (100%)
$-6.4 (-29.91%)
335
What is NLTX (Neoleukin Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on NLTX (Neoleukin Therapeutics) with a proven track record?
Which analyst has the current lower performing score on NLTX (Neoleukin Therapeutics) with a proven track record?
Which analyst has the most public recommendations on NLTX (Neoleukin Therapeutics)?
Which analyst is the currently most bullish on NLTX (Neoleukin Therapeutics)?
Which analyst is the currently most reserved on NLTX (Neoleukin Therapeutics)?
